Archivos de la Sociedad Espanola de Oftalmologia · 2001
[First results after implanting 125 acrylic lenses (Acrysof MA60BM)].
Аннотация на английскомСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Mengual Verdú E, García Sánchez J, Hueso Abancens J R, Toldos J J
Аннотация
PURPOSE: Analysis of the results obtained after the implantation of 125 AcrySof IOLs.
METHODS: A retrospective study in 125 patients with cataracts was performed; 98 without previous eye diseases and 27 with previous eye disease (diabetic retinopathy, traumatic cataract, central corneal leucoma and glaucoma). The phacoemulsification technique chosen depended on the type of cataract (<<chip and flip>>, <<chop>>). Patients were followed up for an average of 9 months.
RESULTS: Functional results (best corrected visual acuity in patients suffering from pre-operative eye diseases were 0.5 or higher in 22.22% of cases, whereas in the group without any disease was higher in 100%. AcrySof was implanted in sulcus when the posterior capsule was ruptured.
CONCLUSIONS: AcrySof is a soft acrylic IOL which can be very safely and effectively implanted, and it did not lead to complications nor to adverse effects in our study. It is a safe, foldable IOL for small incision and phacoemulsification cataract surgery.
METHODS: A retrospective study in 125 patients with cataracts was performed; 98 without previous eye diseases and 27 with previous eye disease (diabetic retinopathy, traumatic cataract, central corneal leucoma and glaucoma). The phacoemulsification technique chosen depended on the type of cataract (<<chip and flip>>, <<chop>>). Patients were followed up for an average of 9 months.
RESULTS: Functional results (best corrected visual acuity in patients suffering from pre-operative eye diseases were 0.5 or higher in 22.22% of cases, whereas in the group without any disease was higher in 100%. AcrySof was implanted in sulcus when the posterior capsule was ruptured.
CONCLUSIONS: AcrySof is a soft acrylic IOL which can be very safely and effectively implanted, and it did not lead to complications nor to adverse effects in our study. It is a safe, foldable IOL for small incision and phacoemulsification cataract surgery.